Who owns DRUGS MADE IN AMER ACQ II CO?
- Ticker: DMIIU
- CUSIP Number: g2851k120
Tip: Access positions for across all investors
Analyze quarterly positions in Drugs Made In Amer Acq Ii with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Drugs Made In Amer Acq Ii stock
Who bought or sold DRUGS MADE IN AMER ACQ II CO this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 2.7M | $27M | 0% | Dec 2025 |
|
| LMR Partners | 2.0M | $20M | 0% | Dec 2025 |
|
| Healthcare Of Ontario Pension Plan Trust Fund | 2.0M | $20M | 0% | Dec 2025 |
|
| Heights Capital Management | 519k | $5.2M | 0% | Dec 2025 |
|
| Westchester Capital Management | 503k | $5.0M | 151% | Dec 2025 |
|
| TIG Advisors | 500k | $5.0M | 0% | Dec 2025 |
|
| Millennium Management | 500k | $5.0M | -75% | Dec 2025 |
|
| Rivernorth Capital Management | 400k | $4.0M | 0% | Dec 2025 |
|
| Steadfast Capital Management | 300k | $3.0M | 0% | Dec 2025 |
|
| Verition Fund Management | 250k | $2.5M | -44% | Dec 2025 |
|
| BlueCrest Capital Management | 250k | $2.5M | 0% | Dec 2025 |
|
| Kepos Capital | 210k | $2.1M | 100% | Mar 2026 |
|
| Gabelli Securities | 180k | $1.8M | 15% | Dec 2025 |
|
| Gabelli Funds | 161k | $1.6M | 18% | Dec 2025 |
|
| Hrt Financial | 137k | $1.4M | 37% | Dec 2025 |
|
| Schonfeld Strategic Advisors | 114k | $1.1M | -13% | Dec 2025 |
|
| Centiva Capital | 100k | $1.0M | 0% | Dec 2025 |
|
| Walleye Trading Advisors | 100k | $1.0M | 0% | Mar 2026 |
|
| Readystate Asset Management | 100k | $1.0M | 0% | Dec 2025 |
|
| Parallax Volatility Advisers | 89k | $892k | -76% | Dec 2025 |
|
| Springbok Capital Management | 50k | $501k | 100% | Dec 2025 |
|
| PenderFund Capital Management | 50k | $497k | -27% | Dec 2025 |
|
| Rangeley Capital | 33k | $326k | 100% | Dec 2025 |
|
| Susquehanna International | 25k | $251k | 100% | Dec 2025 |
|
| Boothbay Fund Management | 25k | $250k | 100% | Dec 2025 |
|
| Robinson Capital Management | 15k | $151k | -40% | Mar 2026 |
|
| UBS Group | 1.8k | $18k | -98% | Mar 2026 |
|
Who sold out of Drugs Made In Amer Acq Ii?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Magnetar Financial | Sep 2025 | 2.7M | $27M |
| Glazer Capital | Sep 2025 | 2.4M | $23M |
| Hudson Bay Capital Management | Sep 2025 | 2.0M | $20M |
| Vivaldi Asset Management | Sep 2025 | 1.9M | $19M |
| Tenor Capital Management | Sep 2025 | 1.5M | $15M |
| Polar Securities | Sep 2025 | 1.5M | $15M |
| CNH Partners | Sep 2025 | 1.5M | $15M |
| HGC Investment Management | Sep 2025 | 1.2M | $12M |
| Aristeia Capital | Sep 2025 | 1.1M | $11M |
| D. E. Shaw & Co | Sep 2025 | 1.0M | $9.9M |
| OMERS Administration Corporation | Sep 2025 | 1.0M | $9.9M |
| Davidson Kempner Capital Management | Sep 2025 | 1.0M | $9.9M |
| Two Sigma Investments | Sep 2025 | 906k | $9.0M |
| Picton Mahoney Asset Management | Sep 2025 | 875k | $8.7M |
| CSS | Sep 2025 | 817k | $8.1M |
| Shaolin Capital Management | Sep 2025 | 800k | $8.0M |
| OZ Management | Sep 2025 | 751k | $7.5M |
| Moore Capital Management | Sep 2025 | 750k | $7.5M |
| Ghisallo Capital Management | Sep 2025 | 750k | $7.5M |
| Radcliffe Capital Management | Sep 2025 | 575k | $5.7M |
| Berkley W R | Sep 2025 | 496k | $4.9M |
| Whitebox Advisors | Sep 2025 | 450k | $4.5M |
| K2 Principal Fund | Sep 2025 | 427k | $4.2M |
| Alpine Partners VI | Sep 2025 | 300k | $3.0M |
| Sona Asset Management | Sep 2025 | 300k | $3.0M |
| Lighthouse Investment Partners | Sep 2025 | 300k | $3.0M |
| Periscope Capital | Sep 2025 | 250k | $2.5M |
| Meteora Capital | Sep 2025 | 200k | $2.0M |
| Saba Capital Management | Sep 2025 | 200k | $2.0M |
| Intl Fcstone | Sep 2025 | 150k | $1.5M |
| Sunrise Partners Limited Partnership | Sep 2025 | 100k | $995k |
| DLD Asset Management | Sep 2025 | 100k | $995k |
| Diameter Capital Partners | Sep 2025 | 100k | $995k |
| Cable Car Capital | Sep 2025 | 100k | $995k |
| Peak6 | Sep 2025 | 100k | $995k |
| Governors Lane | Sep 2025 | 100k | $994k |
| Virtu Financial | Sep 2025 | 50k | $493k |
| Quarry | Sep 2025 | 40k | $398k |
| Qube Research & Technologies | Sep 2025 | 34k | $336k |
| Highbridge Capital Management | Sep 2025 | 25k | $249k |